A detailed history of 683 Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, 683 Capital Management, LLC holds 4,200,000 shares of WVE stock, worth $56.7 Million. This represents 3.13% of its overall portfolio holdings.

Number of Shares
4,200,000
Previous 5,325,000 21.13%
Holding current value
$56.7 Million
Previous $26.6 Million 29.61%
% of portfolio
3.13%
Previous 2.42%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.12 - $9.01 $5.76 Million - $10.1 Million
-1,125,000 Reduced 21.13%
4,200,000 $34.4 Million
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $109,500 - $162,000
-25,000 Reduced 0.47%
5,325,000 $26.6 Million
Q1 2024

May 15, 2024

SELL
$3.54 - $6.84 $885,000 - $1.71 Million
-250,000 Reduced 4.46%
5,350,000 $33 Million
Q4 2023

Feb 14, 2024

SELL
$4.16 - $6.87 $1.04 Million - $1.72 Million
-250,000 Reduced 4.27%
5,600,000 $28.3 Million
Q3 2023

Nov 14, 2023

SELL
$3.56 - $5.75 $644,360 - $1.04 Million
-181,000 Reduced 3.0%
5,850,000 $33.6 Million
Q2 2023

Aug 14, 2023

BUY
$3.51 - $4.69 $108,810 - $145,390
31,000 Added 0.52%
6,031,000 $22 Million
Q4 2022

Feb 14, 2023

SELL
$3.18 - $7.0 $5.16 Million - $11.4 Million
-1,622,348 Reduced 21.28%
6,000,000 $42 Million
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $239,607 - $432,708
101,100 Added 1.34%
7,622,348 $27.5 Million
Q2 2022

Aug 15, 2022

BUY
$1.23 - $3.25 $8.68 Million - $22.9 Million
7,059,201 Added 1527.81%
7,521,248 $24.4 Million
Q1 2022

May 16, 2022

BUY
$2.0 - $3.28 $549,838 - $901,734
274,919 Added 146.91%
462,047 $924,000
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $1.18 Million - $1.94 Million
-375,842 Reduced 66.76%
187,128 $588,000
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $307,923 - $448,346
62,970 Added 12.59%
562,970 $2.76 Million
Q2 2021

Aug 16, 2021

BUY
$5.65 - $7.47 $2.83 Million - $3.74 Million
500,000 New
500,000 $3.33 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.